Related references
Note: Only part of the references are listed.Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia
Tobias Skillback et al.
BRAIN (2015)
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
Sylvia Villeneuve et al.
BRAIN (2015)
The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function
N. Maritza Dowling et al.
NEUROIMAGE (2015)
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
Niklas Mattsson et al.
BRAIN (2015)
Cerebrospinal Fluid β-Amyloid and Phospho-Tau Biomarker Interactions Affecting Brain Structure in Preclinical Alzheimer Disease
Juan Fortea et al.
ANNALS OF NEUROLOGY (2014)
Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease
Usman A. Khan et al.
NATURE NEUROSCIENCE (2014)
Phosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neurons
Rodrigo A. Quintanilla et al.
NEUROBIOLOGY OF DISEASE (2014)
Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a foxed double transgenic model of Alzheimer's disease
Meredith A. Chabrier et al.
NEUROBIOLOGY OF DISEASE (2014)
Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration
Clifford R. Jack et al.
NEUROLOGY (2014)
Association of hypometabolism and amyloid levels in aging, normal subjects
Val J. Lowe et al.
NEUROLOGY (2014)
The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials
Reisa Sperling et al.
NEURON (2014)
TDP-43 interaction with the intracellular domain of amyloid precursor protein induces p53-associated apoptosis
Jing Wang et al.
NEUROSCIENCE LETTERS (2014)
Synergistic Effect of β-Amyloid and Neurodegeneration on Cognitive Decline in Clinically Normal Individuals
Elizabeth C. Mormino et al.
JAMA NEUROLOGY (2014)
Brain amyloid-β oligomers in ageing and Alzheimer's disease
Sylvain E. Lesne et al.
BRAIN (2013)
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
Stephanie J. B. Vos et al.
LANCET NEUROLOGY (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
Catherine M. Roe et al.
NEUROLOGY (2013)
Selective Worsening of Brain Injury Biomarker Abnormalities in Cognitively Normal Elderly Persons With beta-Amyloidosis
David S. Knopman et al.
JAMA NEUROLOGY (2013)
Amyloid-β-Associated Clinical Decline Occurs Only in the Presence of Elevated P-tau
Rahul S. Desikan et al.
ARCHIVES OF NEUROLOGY (2012)
Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET
Rik Ossenkoppele et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging
William J. Jagust et al.
JOURNAL OF NEUROSCIENCE (2012)
Cognitive reserve in ageing and Alzheimer's disease
Yaakov Stern
LANCET NEUROLOGY (2012)
BEaST: Brain extraction based on nonlocal segmentation technique
Simon F. Eskildsen et al.
NEUROIMAGE (2012)
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
D. S. Knopman et al.
NEUROLOGY (2012)
Tau pathology in children and young adults: can you still be unconditionally baptist?
Charles Duyckaerts
ACTA NEUROPATHOLOGICA (2011)
Amyloid-β Associated Volume Loss Occurs Only in the Presence of Phospho-Tau
Rahul S. Desikan et al.
ANNALS OF NEUROLOGY (2011)
Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease
Lars M. Ittner et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
Total and phosphorylated tau protein as biological markers of Alzheimer's disease
Harald Hampel et al.
EXPERIMENTAL GERONTOLOGY (2010)
Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline
Lani K. Clinton et al.
JOURNAL OF NEUROSCIENCE (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease
L. Mosconi et al.
NEUROLOGY (2009)
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Milos D. Ikonomovic et al.
BRAIN (2008)
Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Scott A. Small et al.
NEURON (2008)
What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
W. Jagust et al.
NEUROLOGY (2007)
Tau alteration and neuronal degeneration in tauopathies: mechanisms and models
R Brandt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Share Paper
